- Home
- BOX vs OGN Comparison
BOX vs OGN Comparison
Compare BOX & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOX
- OGN
- Stock Information
- Founded
- BOX 2005
- OGN 1923
- Country
- BOX United States
- OGN United States
- Employees
- BOX N/A
- OGN N/A
- Industry
- BOX Computer Software: Prepackaged Software
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- BOX Technology
- OGN Health Care
- Exchange
- BOX Nasdaq
- OGN Nasdaq
- Market Cap
- BOX 4.6B
- OGN 2.7B
- IPO Year
- BOX 2015
- OGN N/A
- Fundamental
- Price
- BOX $32.30
- OGN $10.85
- Analyst Decision
- BOX Buy
- OGN Buy
- Analyst Count
- BOX 10
- OGN 3
- Target Price
- BOX $38.80
- OGN $17.33
- AVG Volume (30 Days)
- BOX 2.3M
- OGN 3.6M
- Earning Date
- BOX 08-26-2025
- OGN 10-30-2025
- Dividend Yield
- BOX N/A
- OGN 0.74%
- EPS Growth
- BOX 57.29
- OGN N/A
- EPS
- BOX 1.25
- OGN 2.69
- Revenue
- BOX $1,125,704,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- BOX $8.98
- OGN N/A
- Revenue Next Year
- BOX $7.58
- OGN $0.82
- P/E Ratio
- BOX $25.86
- OGN $4.03
- Revenue Growth
- BOX 6.29
- OGN N/A
- 52 Week Low
- BOX $28.00
- OGN $8.01
- 52 Week High
- BOX $38.80
- OGN $20.58
- Technical
- Relative Strength Index (RSI)
- BOX 48.40
- OGN 67.22
- Support Level
- BOX $32.30
- OGN $10.24
- Resistance Level
- BOX $33.01
- OGN $10.95
- Average True Range (ATR)
- BOX 0.62
- OGN 0.41
- MACD
- BOX -0.01
- OGN 0.08
- Stochastic Oscillator
- BOX 25.77
- OGN 94.54
About BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.